FDA Approves New Pfizer and Moderna COVID-19 Vaccines Targeting Omicron Variant XBB.1.5 The US Food and Drug Administration (FDA) has given the green light to newly developed COVID-19 vaccines of Pfizer and Moderna. by Inno Flores
Health COVID: New Omicron Subvariant Surge 40.5% in the US this 2023—Cases Rise this New Year by Isaiah Richard